Danish pharmaceutical company Novo Nordisk (NYSE: NVO) is pioneering a new wave of medical treatment for diabetes and obesity ...

More than 80 companies, out of 110 S&P500 companies that reported earnings this week, delivered EPS wins, but they were not ...

An analysis of the FINEARTS-HF trial, which showed finerenone's benefits in heart failure outcomes, shows no significant ...

The company's financial results should remain strong for a while. Analysts expect earnings per share (EPS) to grow at an ...

First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof ...

The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient value investors.

Mount Yale Investment Advisors LLC lowered its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 4.5% during the ...